Feedback / Questions
dapiglutide (ZP7570) - Zealand Pharma
Dapiglutide: Patent expiry in 2037
(Zealand Pharma)
-
Nov 12, 2021 -
Q3 2021 Results
Patent
•
Short Bowel Syndrome
https://static1.squarespace.com/static/58983777d1758e28995640b4/t/618d2a220f859040d9de951c/1636641316794/ZEAL+3Q+Earnings+slides+-+FINAL.pdf
Nov 12, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious